Filing Details
- Accession Number:
- 0001104659-17-071439
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-01 16:07:15
- Reporting Period:
- 2017-11-29
- Accepted Time:
- 2017-12-01 16:07:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1641640 | Nabriva Therapeutics Plc | NBRV | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1711517 | Maria Francesco Lavino | 1000 Continental Drive Suite 600 King Of Prussia PA 19406 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2017-11-29 | 1,569 | $6.29 | 1,569 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
